RPG
XPH icon

Risk Paradigm Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Risk Paradigm Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-214
Closed -$10K – 387
2015
Q3 		$10K Buy
+214
New +$12.9K 0.02% 209

Other funds holding XPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return

Risk Paradigm Group's XPH Position: Q4 2015 in Review

Risk Paradigm Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2015, closing a stake of 214 shares — an estimated $10K sold.

Risk Paradigm Group first reported a position in XPH in Q3 2015 and held it in 1 quarter. The position peaked at $10K in Q3 2015. 76 funds tracked by Wall St. Rank hold XPH as of Q4 2015.

  • Risk Paradigm Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
  • Risk Paradigm Group sold 214 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2015, an estimated $10K.
  • Risk Paradigm Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2015 and held it in 1 quarter.
  • Risk Paradigm Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $10K in Q3 2015.
  • 76 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2015.

Based on Risk Paradigm Group's 13F filing for Q4 2015, filed 10 Feb 2016.